Synergistic Cytotoxicity of Cafestol and Kahweol With Doxorubicin in Breast Cancer Cells Involves TNF‑α Targeting and NF‑κB Downregulation.

Authors

Layane D Souza, Fábio Junior M Novaes, Carlos Luan A Passos, Ísis S S de Amorim, Pedro Nicolau-Neto, Juliana A Rodrigues, Adilson F Teixeira, Christian Ferreira, Nathalia Alexia N Dos Santos, Priscila G Camargo, Marcelle L F Bispo, Camilo Henrique S Lima, Bruno Ricardo B Pires, Adenilson de Sousa da Fonseca, Claudia M Rezende, Eliane Fialho, Andre Luiz Mencalha

Published in

Archiv der Pharmazie. Volume 359. Issue 10. Pages e70359.

Abstract

Breast cancer (BC) is the most common cancer in women worldwide. Natural compounds have been studied to improve chemotherapy efficiency. Cafestol and kahweol (C&K) are diterpenes from coffee lipid fraction, with potential anticancer activity, whose effects and association with chemotherapeutic drug doxorubicin in BC cells are still unknown. Here, we evaluated the synergistic cytotoxic effects of the C&K with doxorubicin and their molecular mechanisms in BC cells. Cell viability was assessed by the MTT assay. Flow cytometry was used to analyze apoptosis, cell cycle, and NF-κB levels. The microarray assay was performed to identify altered signaling pathways, and molecular docking was utilized to predict the interaction between C&K and TNF-α. In addition, TCGA data were explored to evaluate the clinical association between the expression of C&K-regulated genes and TNF-α/NF-κB pathway genes. C&K was cytotoxic and increased the doxorubicin cytotoxicity, augmented the sub-G0/G1 phase, downregulated TNF-α/NF-κB pathway, decreased NF-κB protein levels, and showed affinity for TNF-α by molecular docking. Moreover, considering the C&K-modulated genes, BLOC1S1 acted as a protective factor for BC, and these genes were negatively correlated with TNF-α/NF-κB genes. Our data suggest that C&K have cytotoxic properties by inhibiting TNF-α/NF-κB pathway and interacting synergistically with doxorubicin in BC cells.

PMID:
42844983
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.